In the adrenergic neurons the amino acid alpha-methyl-meta-tyrosine (alpha-MmT) is converted to metaraminol via the noradrenaline (NA) synthetic pathway. Metaraminol thereby displaces NA from its neuronal stores, and as a consequence NA levels can be drastically reduced, although normal sympathetic tone is essentially maintained by release of newly synthetized NA. In rats treated with alpha-MmT methylester (400 + 200 mg/kg) myocardial NA was reduced to less than 10% of control. Under barbiturate anesthesia, the left coronary artery was ligated, and the incidence of ventricular fibrillation and mortality during a 30-min period was recorded. Before ligation, mean arterial blood pressure was unchanged and heart rate slightly increased by alpha-MmT pretreatment. The energy state of the myocardium was also unchanged by the alpha-MmT pretreatment, as seen in a separate study where hearts from identically treated rats were taken for analysis of glycogen and adenine nucleotides. Thus, alpha-MmT pretreatment appeared not to have reduced the sympathetic tone of the heart. In spite of this, alpha-MmT pretreatment reduced the ventricular fibrillation from 65 to 33% (p less than 0.01; chi 2 test) and mortality from 37 to 15% (p less than 0.05). The results indicate an important role of myocardial NA stores in the development of early ischemic arrhythmias.
No takes yet. Share an insight, caveat, or question.
Abrahamsson et al. (1985) studied this question.